← FDA Drug Approvals (Drugs@FDA)

ADAKVEO

BLA · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2019-11-15

Drug application

FDA Application #

BLA761128

Application type

Biologics License Application

Brand name

ADAKVEO

Generic name

CRIZANLIZUMAB

Active ingredients

CRIZANLIZUMAB-TMCA

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

NOVARTIS PHARMS CORP

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2019-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown